December 5-7, 2017
Boston, MA

Optimizing The Development Of Biologics
Through The Application Of Computational Tools

Computational tools have the potential to enable rapid material-free developability assessments of large molecule candidates. With wide spanning roles across early discovery through to downstream development activities, when utilized effectively, computational techniques can shorten timelines and enhance the cost-effectiveness of biologic drug development.

The 3rd Annual Computational Drug Development for Biologics Summit will once again unite computational leaders from pioneering pharmaceutical organizations, academic and software development labs. Across 3 days of jam-packed content, explore the utility and application of computational tools to the development of biologic drugs.

2017 Highlights Included:

  1. New insights into how computational tools are being utilized to optimize the developability of large molecules from discovery, design and PKPD
  2. A spotlight on the organizational barriers preventing industry wide adoption and implementation
  3. Greater understanding for the applications of deep learning and AI in computer-aided design of biologics
  4. A greater focus on the landscape beyond MAb’s

To receive updates on the 2018 agenda and speaker panel as they are released, please register your interest here. We’ll be sure to reach out to you with important updates as they occur.

“I'm impressed by how much I learned by attending the conference. It's a great opportunity to learn the key issues facing the industry and various strategies to address them.”

Liwei Li, Senior Scientist, EMD Serono

"Strong program, great speakers and a genuine focus on identifying solutions"

Novartis

"I enjoyed this conference and look forward to future conferences around the developing field"

Macromoltek

An Open Letter
From Stanley Krystek
(2017 Chairman)
Chairman Icon
Download Your Copy

Media Partner